Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Depreciation & Amortization (CF) (2022 - 2026)

Centessa Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 4 years, most recently at $241000.0 for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 4.78% to $241000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $921000.0 through Dec 2025, down 2.23% year-over-year, with the annual reading at $921000.0 for FY2025, 2.23% down from the prior year.
  • Depreciation & Amortization (CF) was $241000.0 for Q4 2025 at Centessa Pharmaceuticals, up from $237000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $246000.0 in Q4 2023 and troughed at $28000.0 in Q1 2022.
  • The 4-year median for Depreciation & Amortization (CF) is $233000.0 (2024), against an average of $175250.0.
  • Year-over-year, Depreciation & Amortization (CF) soared 640.62% in 2023 and then fell 9.58% in 2025.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $36000.0 in 2022, then soared by 583.33% to $246000.0 in 2023, then dropped by 6.5% to $230000.0 in 2024, then grew by 4.78% to $241000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Depreciation & Amortization (CF) are $241000.0 (Q4 2025), $237000.0 (Q3 2025), and $226000.0 (Q2 2025).